News | July 15, 2025
WHO, ITU, and WIPO release new report on AI use in traditional medicine
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
The company’s largest center for medical device applications, serving the entire Asian market
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
The company showcased three core programs developed through this platform
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
Subscribe To Our Newsletter & Stay Updated
